×
Customize
?
Start
Cancer Types
Quick Links
Award Programs
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
MPN
Jessica Skarzynski
A new analysis of the myMPN Patient Registry has led to some exciting new discoveries, according to researchers.
Beth Fand Incollingo
The U.S. Food and Drug Administration (FDA) will give a priority review to the experimental targeted drug fedratinib as a potential treatment for the blood cancer myelofibrosis.
Jean Diesch
Any action, larger or small, can make a major impact in the lives of patients with a myeloproliferative neoplasm.
Celia Miltz
After her daughter was diagnosed, Celia Miltz founded the Friends of ET Research.
Angela Fleischman, M.D., Ph.D.
Angela Fleischman, M.D., Ph.D., is particularly excited for improvements in treating early-stage disease.
Richard French
After realizing how little awareness there was about MPNs, one advocate looked to his TV background to help.
Jaden Persaud
Jaden Persaud knows firsthand how a MPN diagnosis can affect a family's life.
Brielle Benyon
In this week's episode of the CURE Talks Cancer podcast, hear from some of our recent MPN Heroes.
LISA MACHADO
The 2018 MPN Champion Awards celebrate Canadian patients, caregivers and supporters.
Marcy Worthington
Understanding the disease and treatments are key aspects of being a patient advocate, explained MPN Hero Marcy Worthington.